GVHD PROPHYLAXIS WITH METHOTREXATE IN HAPLOIDENTICAL HCT USING POSTTRANSPLANT CYCLOPHOSPHAMIDE: A PHASE IB/II CLINICAL TRIAL (NCT04622956)
G Fatobenea, AM Ferreiraa, LJ Otuyamaa, LB Ribeirob, I Colturatoc, JGD Santosa, B Moraesa, V Colturatoc, A Vigoritob, V Rochaa
a LIM/03, Laboratório de Medicina Laboratorial, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
b Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
c Hospital Amaral Carvalho, Jaú, SP, Brazil
Read
354
Timeswas read the article
121
Total PDF
233
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 0 | 1 | 1 |
| 2025 April | 35 | 5 | 40 |
| 2025 March | 42 | 10 | 52 |
| 2025 February | 27 | 18 | 45 |
| 2025 January | 40 | 11 | 51 |
| 2024 December | 28 | 22 | 50 |
| 2024 November | 39 | 33 | 72 |
| 2024 October | 22 | 21 | 43 |
